ClinicalTrials.Veeva

Menu

Nosocomial COVID-19 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021 (COVIDIN)

C

Centre Hospitalier Régional Metz-Thionville

Status

Completed

Conditions

SARS CoV 2 Infection

Treatments

Other: Nosocomial SARS-COV 2 Infection proportion

Study type

Observational

Funder types

Other

Identifiers

NCT05567874
2022-09Obs-CHRMT

Details and patient eligibility

About

The rate of nosocomial SARS-CoV2 infections found in the different studies since the beginning of the pandemic is very variable (<1% in hospitals in the USA to about 20% in a British hospital). Mortality related to these nosocomial SARS-CoV2 infections is higher than in the general population. The risk factors identified for this nosocomial acquisition are multiple. We were confronted with nosocomial acquisitions and cluster situations in the services, without exhaustive data to measure these phenomena, and we lacked data to consider areas for improvement.

The objectives of this study are to determine the proportion of nosocomial SARS COV 2 infections in the total number of patients hospitalized with a Covid-19 infection at the CHR Metz-Thionville in 2021, and to describe the characteristics of this population.

Enrollment

216 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients hospitalised at the CHR Metz-Thionville in medicine, surgery and obstetrics (MCO) or geriatric follow-up and rehabilitation care (SSR) units, in 2021 for a Covid-19 infection defined by the existence of a positive PCR result for SARS-CoV2 during the stay, or by the existence of an ICD10 code for COVID in the PMSI data of the health care establishment

Exclusion criteria

  • Opposition to participate in the study after reading the patient information note.

Trial design

216 participants in 3 patient groups

SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in 2021 during the first period
Description:
SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in April 2021
Treatment:
Other: Nosocomial SARS-COV 2 Infection proportion
SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in 2021 during the second period
Description:
SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville from June to September 2021
Treatment:
Other: Nosocomial SARS-COV 2 Infection proportion
SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in 2021 during the third period
Description:
SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in December 2021
Treatment:
Other: Nosocomial SARS-COV 2 Infection proportion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems